Invetech and AiCella Announce Strategic Collaboration to Advance Cell Therapy Innovation
Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today announced a strategic collaboration with AiCella.
June 27, 2025
by PR Newswire
Key Considerations for Cold Chain Distribution in Cell Therapy
In this article, we focus on the key factors that influence cold chain distribution in cell therapy, including temperature stability, packaging and handling challenges, and compliance with regulatory standards.
October 16, 2024
by Saher Haider
Advancing Cryogenic Cold Chain Technology for Cell Therapy Products
Unlike conventional temperature-sensitive pharmaceutical products, cell therapy products have the most stringent requirements for cold chain logistics.In this article, we will dive deeper into cryogenic technology used at every step of the cold chain supp
October 15, 2024
by Saher Haider
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery
TheWell Bioscience is a pioneer in the field of animal-free hydrogels and bioinks, critical components for the creation of 3D biomimicking platforms.
April 10, 2024
by PharmaSources
Research progress of dual-target CAR-T in China from the perspective of the ASCO 2023
At the ASCO this year, Gracell Bio announced the long-term follow-up data of its multi-center clinical study of CAR-T therapy with GC012F for recurrent/refractory multiple myeloma (R/R MM) in the form of oral report at the annual meeting.
June 27, 2023
by Xiaobin/PharmaSources
T-CURX GmbH Announces Senior Leadership Appointments to Significantly Bolster Clinical Team
Appointments of co-founder Professor Michael Hudecek as Chief Medical Officer and Dr. Karl Schumacher as Chief Clinical Officer.
June 7, 2023
by PharmaSources
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership for N-LIfT Allogeneic Neutrophil Based Cell Therapy
LIfT BioSciences and Minaris Regenerative Medicine GmbH have entered into a development and manufacturing partnership for N-LIfT, LIfT’s first-in-class neutrophil progenitor based Leukocyte Infusion Therapy.
February 16, 2023
by PharmaSources
NASDAQ Biopharma IPOs in the First Half of Q1 2022
So far in the first half of Q1 2022 seven biopharma companies have IPO’d on the NASDAQ.
March 1, 2022
by David Orchard-Webb
Fujifilm Acquires Cell Therapy Mfg. Facility from Atara Biotherapeutics
Expands its advanced therapies CDMO business .
January 27, 2022
by contractpharma
Cryoport Partners with Cell Matters to Deliver Cryopreservation Services
Further strengthens Cryport’s capabilities in the EMEA region.
January 27, 2022
by contractpharma
Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing
Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a Series A financing of $80 million, led by the impact investment arm of Bayer AG - Leaps by Bayer - 8VC, and Humboldt Fund.
January 26, 2022
by WorldPharmaNews
Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma
Lion TCR Pte Ltd today announced that it has received Fast Track Designation from United States Food and Drug Administration (U.S. FDA) for LioCyx-M004, autologous T-cells transfected with mRNA encoding Hepatitis B surface antigen...
December 23, 2021
by prnasia